LU5 Neuromuscular

  1. Which of the following neuromuscular blocking agents is classified as a depolarizing agent? A) Atracurium
    B) Rocuronium
    C) Succinylcholine
    D) Vecuronium

  2. What is the primary mechanism of action of non-depolarizing neuromuscular blockers? A) Agonizing muscarinic receptors
    B) Antagonizing nicotinic receptors
    C) Inhibiting acetylcholinesterase
    D) Stimulating acetylcholine release

  3. Which of the following is a side effect of succinylcholine? A) Hypokalemia
    B) Bradycardia
    C) Hypotension
    D) Hypernatremia

  4. What is the antidote for reversing the effects of non-depolarizing neuromuscular blockers? A) Succinylcholine
    B) Neostigmine
    C) Atropine
    D) Diazepam

  5. Which neuromuscular blocking agent is most likely to cause histamine release? A) Rocuronium
    B) Atracurium
    C) Vecuronium
    D) Succinylcholine

  6. Succinylcholine is rapidly metabolized by which enzyme? A) Acetylcholinesterase
    B) Pseudocholinesterase
    C) Monoamine oxidase
    D) Cytochrome P450

  7. Which of the following is a competitive neuromuscular blocking agent? A) Succinylcholine
    B) Pancuronium
    C) Halothane
    D) Neostigmine

  8. What is a common clinical use of neuromuscular blocking agents? A) Pain relief
    B) Muscle relaxation during surgery
    C) Reducing blood pressure
    D) Treating infections

  9. Which of the following conditions increases the risk of hyperkalemia with succinylcholine use? A) Diabetes mellitus
    B) Chronic kidney disease
    C) Nerve damage
    D) Asthma

  10. Which drug is used to prevent the muscarinic side effects of neostigmine? A) Atropine
    B) Succinylcholine
    C) Diazepam
    D) Dantrolene

  11. What is the typical duration of action for succinylcholine? A) 1-2 minutes
    B) 5-8 minutes
    C) 20-30 minutes
    D) 1-2 hours

  12. Which of the following is NOT a property of neuromuscular blocking agents? A) Sedation
    B) Muscle relaxation
    C) Lack of analgesia
    D) Lack of amnesia

  13. What condition is characterized by a life-threatening reaction to succinylcholine and halothane? A) Malignant hyperthermia
    B) Anaphylaxis
    C) Hyperkalemia
    D) Bradycardia

  14. Which of the following agents can reverse the effects of atracurium? A) Atropine
    B) Neostigmine
    C) Succinylcholine
    D) Diazepam

  15. Which neuromuscular blocking agent has a short duration due to rapid destruction by plasma pseudocholinesterase? A) Vecuronium
    B) Atracurium
    C) Succinylcholine
    D) Rocuronium

  16. What is a potential adverse effect of succinylcholine on intraocular pressure? A) Decreased intraocular pressure
    B) Increased intraocular pressure
    C) No effect on intraocular pressure
    D) Causes retinal detachment

  17. Which of the following is true about the phase 1 block of succinylcholine? A) It causes repolarization of the end plate
    B) It results in flaccid paralysis
    C) It is rapidly reversible by anticholinesterase
    D) It blocks muscarinic receptors

  18. Which agent is a structural analog of acetylcholine and acts as a non-depolarizing blocker? A) Succinylcholine
    B) Atracurium
    C) Halothane
    D) Dantrolene

  19. What is the effect of neostigmine on non-depolarizing neuromuscular blockers? A) Enhances their effect
    B) Antagonizes their effect
    C) Has no effect
    D) Converts them into depolarizing agents

  20. Which condition can prolong the effects of succinylcholine due to enzyme deficiency? A) Absence of pseudocholinesterase
    B) Absence of acetylcholinesterase
    C) Hyperkalemia
    D) Hypokalemia

  21. Which neuromuscular blocker is known for causing muscular fasciculations before paralysis? A) Rocuronium
    B) Atracurium
    C) Succinylcholine
    D) Vecuronium

  22. Which agent should be administered before neostigmine to avoid muscarinic effects? A) Dantrolene
    B) Atropine
    C) Diazepam
    D) Succinylcholine

  23. What is the primary use of succinylcholine in clinical practice? A) Pain relief
    B) Rapid sequence intubation
    C) Blood pressure management
    D) Sedation

  24. Which neuromuscular blocking agent is metabolized spontaneously by a passive chemical process? A) Vecuronium
    B) Atracurium
    C) Succinylcholine
    D) Pancuronium

  25. Which of the following is a side effect of repeated succinylcholine injections? A) Tachycardia
    B) Hypertension
    C) Bradycardia
    D) Hyperglycemia

  26. What is the effect of succinylcholine on intragastric pressure? A) Decreases it
    B) Increases it
    C) No effect
    D) Causes gastric ulceration

  27. Which condition can result from the use of succinylcholine in patients with burns or trauma? A) Hypokalemia
    B) Hyperkalemia
    C) Hyponatremia
    D) Hypernatremia

  28. Which of the following drugs is a non-depolarizing neuromuscular blocker? A) Succinylcholine
    B) Pancuronium
    C) Halothane
    D) Neostigmine

  29. What is the clinical use of neuromuscular blockers in electroconvulsive therapy (ECT)? A) Inducing anesthesia
    B) Preventing muscle trauma
    C) Reducing anxiety
    D) Providing analgesia

  30. Which of the following is NOT reversed by anticholinesterase? A) Atracurium
    B) Rocuronium
    C) Succinylcholine
    D) Vecuronium

  31. Which of the following agents can cause respiratory paralysis as a side effect? A) Succinylcholine
    B) Neostigmine
    C) Atropine
    D) Diazepam

  32. Which neuromuscular blocker increases potassium release from muscles? A) Atracurium
    B) Vecuronium
    C) Succinylcholine
    D) Pancuronium

  33. What is a common symptom following succinylcholine administration? A) Muscle pain
    B) Euphoria
    C) Hypertension
    D) Sedation

  34. Which of the following is an effect of succinylcholine on the cardiovascular system? A) Tachycardia
    B) Bradycardia
    C) Hypertension
    D) Vasodilation

  35. What is the effect of succinylcholine on intraocular pressure? A) Decreases it
    B) Increases it
    C) No effect
    D) Causes blindness

  36. Which of the following is used to manage malignant hyperthermia? A) Neostigmine
    B) Atropine
    C) Dantrolene
    D) Succinylcholine

  37. What is the typical onset of action for succinylcholine? A) 30 seconds
    B) 2-3 minutes
    C) 10-15 minutes
    D) 20-30 minutes

  38. Which neuromuscular blocker is most potent? A) d-Tubocurarine
    B) Atracurium
    C) Succinylcholine
    D) Rocuronium

  39. Which of the following neuromuscular blockers has no ganglion blocking action? A) Succinylcholine
    B) Pancuronium
    C) d-Tubocurarine
    D) Gallamine

  40. Which neuromuscular blocker is suitable for short surgical procedures due to its short duration of action? A) Vecuronium
    B) Atracurium
    C) Succinylcholine
    D) Pancuronium

Answers:

  1. C

  2. B

  3. B

  4. B

  5. B

  6. B

  7. B

  8. B

  9. C

  10. A

  11. B

  12. A

  13. A

  14. B

  15. C

  16. B

  17. B

  18. B

  19. B

  20. A

  21. C

  22. B

  23. B

  24. B

  25. C

  26. B

  27. B

  28. B

  29. B

  30. C

  31. A

  32. C

  33. A

  34. B

  35. B

  36. C

  37. A

  38. C

  39. A

  40. C